An analytical study of iboga alkaloids contained in Tabernanthe iboga-derived products offered by ibogaine treatment providers
Archives of Clinical Psychiatry (São Paulo) April 1, 2020 José Carlos Bouso, I. Fornís, Mireia Ventura et al. 15 citations
Background: Therapeutic properties of ibogaine in the treatment of addiction are attracting both clinicians and patients to its use. Since ibogaine is not an authorized medicine, the quality of these products is not always known, increasing the probability of adverse reactions. Objective: This study collects different types of iboga-derived samples from treatment providers, vendors and online...
DOI: 10.1590/0101-60830000000231 (opens in new tab)
Traditional medicine
Alkaloids